Plain-English translation of NCT06429098 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether , a newer cancer medication, works well when combined with other drugs to treat a specific type of acute myeloid leukemia (a blood cancer). The study aims to see if this medication combination can help patients achieve remission—meaning the cancer goes away or is greatly reduced. Researchers are particularly interested in whether this approach works better than older treatments and causes fewer side effects.
This medication combination is being tested because doctors want to find a gentler treatment option for this type of blood cancer that avoids older, more toxic chemotherapy drugs. By studying how well the treatment works and how safe it is, researchers hope to offer patients better quality of life while still fighting their cancer effectively.
You likely qualify if…
You likely don't qualify if…
You would take the medication by mouth daily for 28 days, combined with injections or IV infusions on certain days, for 2 treatment cycles. If your cancer responds well, your doctor will assess your overall health; if you're fit enough, you'll receive additional strengthening treatment cycles, or if not, you'll continue the original medication combination. Throughout the trial, you'll have regular clinic visits and blood tests to monitor how the treatment is working and watch for side effects, with follow-up appointments continuing for months after treatment ends.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
China